Patents by Inventor Isabel Milan Chu

Isabel Milan Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TMEFF1 antibodies and antibody drug conjugates
    Patent number: 11981732
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: May 14, 2024
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20220298239
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 22, 2022
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • Anti-TMEFF1 antibodies and antibody drug conjugates
    Patent number: 11312769
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: April 26, 2022
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20200109194
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: March 22, 2018
    Publication date: April 9, 2020
    Applicant: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet